CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	95,880	104,941	57,564	33,175	32,187	16,880	Upgrade
Market Cap Growth	17.03%	82.30%	73.52%	3.07%	90.68%	39.23%	Upgrade
Last Close Price	106.48	118.22	64.70	37.56	53.48	27.21	Upgrade
PE Ratio	65.27	42.71	19.92	-	9.42	11.86	Upgrade
PS Ratio	6.13	4.97	3.93	7.25	1.76	2.71	Upgrade
PB Ratio	1.90	2.12	1.26	0.72	0.75	0.56	Upgrade
P/FCF Ratio	-	20.19	-	-	-	-	Upgrade
P/OCF Ratio	-	19.76	-	-	-	-	Upgrade
Debt / Equity Ratio	0.75	0.83	0.86	0.82	0.69	0.84	Upgrade
Debt / FCF Ratio	-	7.89	-	-	-	-	Upgrade
Asset Turnover	-	0.08	0.06	0.02	0.14	0.12	Upgrade
Quick Ratio	-	0.73	1.03	1.01	0.91	2.03	Upgrade
Current Ratio	-	0.79	1.11	1.13	1.03	2.17	Upgrade
Return on Equity (ROE)	-	8.15%	9.42%	-0.74%	25.17%	14.36%	Upgrade
Return on Assets (ROA)	-	1.45%	1.81%	-0.15%	7.24%	7.27%	Upgrade
Earnings Yield	1.53%	2.34%	5.09%	-1.31%	10.86%	8.69%	Upgrade
FCF Yield	-	4.95%	-2.19%	-13.42%	-16.70%	-26.50%	Upgrade
Dividend Yield	0.36%	0.47%	0.80%	1.37%	0.80%	1.45%	Upgrade
Payout Ratio	-	19.90%	16.48%	-	8.87%	17.67%	Upgrade
Buyback Yield / Dilution	-3.58%	-2.97%	-21.65%	-18.39%	-8.46%	-4.66%	Upgrade
Total Shareholder Return	-3.22%	-2.50%	-20.85%	-17.02%	-7.66%	-3.21%	Upgrade

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.